136 related articles for article (PubMed ID: 10865088)
21. A neuropathological study of periventricular white matter hyperintensities in major depression.
Thomas AJ; O'Brien JT; Barber R; McMeekin W; Perry R
J Affect Disord; 2003 Sep; 76(1-3):49-54. PubMed ID: 12943933
[TBL] [Abstract][Full Text] [Related]
22. [Subcortical hyperintensities on magnetic resonance imaging: a comparison of normal and depressed elderly subjects].
Novaretti TM; Marcolin MA; Meira S; Gelás PL; Baudelin CG; Bottino CM
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):754-60. PubMed ID: 11593278
[TBL] [Abstract][Full Text] [Related]
23. Metabolic changes of subcortical structures in intractable focal epilepsy.
Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
[TBL] [Abstract][Full Text] [Related]
24. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
25. Impaired cerebral glucose metabolism in eclampsia: a new finding in two cases.
Zunker P; Georgiadis AL; Czech N; Golombeck K; Brossmann J; Deuschl G
Fetal Diagn Ther; 2003; 18(1):41-6. PubMed ID: 12566775
[TBL] [Abstract][Full Text] [Related]
26. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.
DeCarli C; Murphy DG; Tranh M; Grady CL; Haxby JV; Gillette JA; Salerno JA; Gonzales-Aviles A; Horwitz B; Rapoport SI
Neurology; 1995 Nov; 45(11):2077-84. PubMed ID: 7501162
[TBL] [Abstract][Full Text] [Related]
27. A combined neuropsychological and brain imaging study of obstructive sleep apnea.
Yaouhi K; Bertran F; Clochon P; Mézenge F; Denise P; Foret J; Eustache F; Desgranges B
J Sleep Res; 2009 Mar; 18(1):36-48. PubMed ID: 19250174
[TBL] [Abstract][Full Text] [Related]
28. [Cerebral positron emission tomographic study in systemic lupus erythematosus].
Csépány T; Gulyás B; Trón L; Szakáll S; Kiss E; Kollár J; Sikula J; Szegedi G; Csiba L
Orv Hetil; 1997 Aug; 138(31):1947-52. PubMed ID: 9280887
[TBL] [Abstract][Full Text] [Related]
29. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging.
Hatazawa J; Shimosegawa E; Satoh T; Toyoshima H; Okudera T
Stroke; 1997 Oct; 28(10):1944-7. PubMed ID: 9341700
[TBL] [Abstract][Full Text] [Related]
30. [Reduced metabolism in cerebral cortex correlates with MRI changes and cognitive dysfunction in patients with disseminated sclerosis].
Blinkenberg M; Rune K; Jensen CV; Ravnborg MH; Kyllingsbaek S; Holm S; Paulson OB; Sørensen PS
Ugeskr Laeger; 2001 Jul; 163(27):3788-92. PubMed ID: 11466987
[TBL] [Abstract][Full Text] [Related]
31. Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain.
Heidenreich JO; Klopstock T; Schirmer T; Saemann P; Mueller-Felber W; Auer DP
AJR Am J Roentgenol; 2006 Sep; 187(3):820-4. PubMed ID: 16928952
[TBL] [Abstract][Full Text] [Related]
32. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities.
ten Dam VH; van den Heuvel DM; de Craen AJ; Bollen EL; Murray HM; Westendorp RG; Blauw GJ; van Buchem MA
Radiology; 2007 Apr; 243(1):198-203. PubMed ID: 17329688
[TBL] [Abstract][Full Text] [Related]
33. White matter hyperintensities and chronicity of depression.
Heiden A; Kettenbach J; Fischer P; Schein B; Ba-Ssalamah A; Frey R; Naderi MM; Gulesserian T; Schmid D; Trattnig S; Imhof H; Kasper S
J Psychiatr Res; 2005 May; 39(3):285-93. PubMed ID: 15725427
[TBL] [Abstract][Full Text] [Related]
34. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
[TBL] [Abstract][Full Text] [Related]
35. Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
Kim HW; Oh M; Oh JS; Oh SJ; Lee SJ; Chung SJ; Kim JS
PLoS One; 2017; 12(1):e0169928. PubMed ID: 28085923
[TBL] [Abstract][Full Text] [Related]
36. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
[TBL] [Abstract][Full Text] [Related]
37. Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy.
Thorngren-Jerneck K; Ohlsson T; Sandell A; Erlandsson K; Strand SE; Ryding E; Svenningsen NW
Pediatr Res; 2001 Apr; 49(4):495-501. PubMed ID: 11264432
[TBL] [Abstract][Full Text] [Related]
38. Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy.
Sabri O; Hellwig D; Schreckenberger M; Cremerius U; Schneider R; Kaiser HJ; Doherty C; Mull M; Ringelstein EB; Buell U
J Nucl Med; 1998 Jan; 39(1):147-54. PubMed ID: 9443754
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
Zhang Q; Tian T; Wang L; Qiu H; Li D
Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
